Abstract
Purpose. Transport of dopamine (DA) across the blood-brain barrier (BBB) was examined in guinea pigs.
Methods. In situ brain perfusion (1–10 min), capillary depletion, and high pressure liquid chrbmatography (HPLC) were used.
Results. There was a saturable DA influx into the brain with a KM of 389 ± 55 nM, and a VMAXof 1.95 ± 0.25 pmol/min/g of brain. The diffusion constant, KD, was not significantly different from zero. About 0.5% of DA remained tightly bound to cerebral microvessels isolated from the perfused brain. DA influx into the brain was not altered by the monoamine oxidase-B (MAO-B) inhibitor pargyline (50 µM). HPLC analysis of perfused brain confirmed transport of intact DA, and no detectable increases in DA metabolites were observed. At perfusate concentrations of 500 nM, several dopaminergic receptor antagonists inhibited [3H]-DA (21 nM) influx; the percent inhibitions for the mixed D1 and D2 antagonists haloperidol and chlorpromazine, the D1, antagonist SCH-23390, and the D2 antagonist spiperone were 90%, 68%, 77%, and 50%, respectively. Brain perfusion with nicotine (500 nM) inhibited DA uptake by 86%. This nicotine effect was not altered by mecamylamine, but was partially prevented by the nicotinic receptor antagonist hexamethonium.
Conclusions. a) A significant cerebrovascular permeability to intact DA is mediated by a MAO-B independent specific transport system at the BBB, b) this system could be inhibited by D1, and D2 DA receptor antagonists, and c) DA blood-to-brain transport was inhibited by nicotine.
Similar content being viewed by others
REFERENCES
M. A. Menza, L. I. Golbe, R. A. Cody, and N. E. Forman. Dopamine related personality traits in Parkinson's disease, Neurology 43:505–508 (1993).
D. J. Diehl and S. Gershon. The role of dopamine in mood disorders, Comprehensive Psychiatry 33(2):115–120 (1992).
W. H. Oldendorf. Brain uptake of radiolabeled amino acids, amines and hexoses after arterial injection, Am. J. Physiol. 221:1629–1638 (1971).
S. I. Harik, J. J. Riachi, R. N. Kalaria, and J. C. Lamanna. The role of the blood-brain barrier in preventing MPTP toxicity. In B. B. Johansson, C. Owman, and H. Widner (eds), Pathophysiology of the Blood-Brain Barrier, Elsevier Science Publishers, Cambridge, 1990, pp. 255–267.
C. L. Martel, J. B. Mackic, M. H. Weiss, J. G. McComb, and B. V. Zlokovic. Transport and binding of circulating dopamine at the blood-brain barrier in guinea pigs, Soc. Neurosci. Abstr. 19:695 (1993).
B. V. Zlokovic. Cerebrovascular permeability to peptides: manipulations of transport systems at the blood-brain barrier, Pharmaceut. Res. 12:1395–1406 (1995).
F. Basic, S. Uematsu, R. M. McCarron, and M. Spatz. Dopaminergic receptors linked to adenylate cyclase in human cerebromicro-vascular endothelium, J. Neurochem. 57:1774–1780 (1991).
S. Grady, M. J. Marks, S. Wonnacott, and A. C. Collins. Characterization of nicotinic receptor-mediated [3H]dopamine release from synaptosomes prepared from mouse striatum, J. Neurochem. 59:848–856 (1992).
H. Yamashita, S. Kitayama, Y.-X Zhang, T. Takahashi, T. Dohi, and S. Nakamura. Effects of nicotine on dopamine uptake in COS cells possessing the rat dopamine transporter and in PC12 cells, Biochem. Pharmacol. 49:742–745 (1995).
D. Triguero, J. Buciak, and W. M. Pardridge. Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins, J. Neurochem. 54:1882–1888 (1990).
P. W. Kalivas. Sensitization to repeated enkephalin administration into the ventral tegmental area of the rat. II. Involvement of the mesolimbic dopamine system, J. Pharmacol. Exp. Ther. 235:544–550 (1985).
T. Suhara, K. Nakayama, O. Inoue, H. Fukuda, M. Shimizu, A. Mori, and Y. Tateno. D1 dopamine receptor binding in mood disorders measured by positron emission tomography, Psychopharm. 106:14–18 (1992).
J. L. Corey, M. W. Quick, N. Davidson, H. A. Lester, and J. Guastella. A cocaine-sensitive Drosophila serotonin transporter: cloning, expression, and electrophysiological characterization, Proc. Natl. Acad. Sci. USA 91: 1188–1192 (1994).
M. A. Hediger, Y. Kanai, G. You, and S. Nussberger. Mammalian ion-coupled solute transporters, J. Physiol. 482:7S–17S (1995).
B. Greenwood, E. Blank, and W. J. Dodds. Nicotine stimulates esophageal peristaltic contractions in cats by a central mechanism, Am. J. Physiol. 262:G567–G571 (1992).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Martel, C.L., Mackic, J.B., Adams, J.D. et al. Transport of Dopamine at the Blood-Brain Barrier of the Guinea Pig: Inhibition by Psychotropic Drugs and Nicotine. Pharm Res 13, 290–295 (1996). https://doi.org/10.1023/A:1016007601794
Issue Date:
DOI: https://doi.org/10.1023/A:1016007601794